Sirtuins 
Introduction
Sirtuins belong to the broad category of histone deacetylases (HDACs), enzymes that modulate signalling proteins, enzymes and transcription factors (TFs) via removal of lysine acetylation. Acylations (including Lys acetylation) are an increasingly recognized, evolutionarily conserved category of post-translational protein modifications; the action of HDACs thus allows highly controlled spatiotemporal regulation of protein activity, interactions and localization. Crucial aspects of cellular homoeostasis depend on acylations including the prevention and mitigation of stress and the removal of the resulting damage. There are over 45 HDAC enzymes identified in eukaryotes, divided into 4 groups (classes) according to their homology to yeast HDACs [38] . Class I enzymes (HDAC1 to -3 and HDAC8) show the stron-gest similarity to yeast Rpd3 (reduced potassium dependency 3), while class II enzymes are related to yeast HDA1 and fall into two sub-classes according to the same structural criterion: IIa (HDAC4 to -7 and -9) and IIb (HDAC6, -10). The seven known mammalian class III enzymes are termed sirtuins (SIRT1 to -7; the name stems from a yeast homologue dubbed silent information regulator 2) (Table I) . Sirtuins are the only HDACs to use NAD + for the reaction; these enzymes localize to various cellular compartments (Table I) [132, 207, 234] including cytosol (SIRT1, -2), mitochondria (SIRT3-5), and nucleus (SIRT1, -6 and -7, plus cell cycle-dependent transient re-location of SIRT2). Class IV includes only one enzyme, HDAC11.
The unique dependence on NAD + availability makes sirtuins excellent sensors of metabolic condition of the cell. Sirtuins transfer the acetyl group removed from a protein to the ADP-ribose moiety of NAD + ; this causes the NAD + molecule to break down to nicotinamide and O-acetyl-ADP-ribose (OAADPR), which are SIRT auto-inhibitory compounds. Moreover, OAADPR undergoes rather extensive metabolism and may serve as a signalling molecule capable of modulating gene silencing, ion channel opening, and the function of macro-domain histone proteins [197] . Nicotinamide in turn is also used to re-synthesize NAD + , and this aspect has additional importance for SIRT activity. However, despite the significant sequence homology between sirtuins, not all of them are deacetylases, and some display other enzymatic activities (Table I) . SIRT5 has been found to remove succinyl and malonyl groups from lysines in proteins [47] . SIRT3 and SIRT6 can ADP-ribosylate proteins [113, 182] in addition to their deacetylase function [53, 90] . Moreover, SIRT4 displays protein mono(ADP-ribosyl)transferase activity and no detectable deacetylation capability [5, 71] .
Despite the somewhat misleading 'histone deacetylase' term, sirtuins also (un)modify a vast spectrum of non-histone proteins. The targets of SIRT1, which is by far the best characterized sirtuin, include histones, a broad range of stress signalling proteins, and transcription factors (TFs) ( Table I) . SIRT1 is mainly involved in the regulation of the stress response and macromolecular repair (through its influence on p53 [64] , heat shock factor HSF1 [114] , forkhead box subgroup O -FOXO proteins [25] , peroxisome proliferator-activated receptor -PPAR family [159] , Ku70 [85] ), anti-inflammatory response (via NF-κB [136, 230] ), exerts a pro-survival influence (through IIS -insulin/ IGF-I signalling [210] ), and modulates the generation of mitochondria [66] . Long-term experimental SIRT1 activation in vivo is able to retard the onset of agerelated metabolic stress and mortality [136] . Its roles in neuronal plasticity/learning and memory phenomena have also been demonstrated [59] .
The extensive links of sirtuins with stress signalling, cellular metabolism rates and energy status parallel their cross-talk with the family of poly(ADPribose) polymerases (PARPs). PARP-1, the oldest known and best described member of the family, is a 113 kDa protein (in humans) involved in the regulation of chromatin structure, DNA repair, gene expression, and cell death. Its moderate activation is necessary for cellular survival under stress [60] . However, PARP-1 overactivation by glutamate-evoked NO (nitric oxide) production mediates neuronal death in a number of pathological conditions [2, 43, 188] . The complexity of the enzyme's engagement in the modulation of the cell survival/death equilibrium is additionally reflected by the large changes of its stress response capacity with age [189] . Moreover, the activity of PARPs can be influenced by glutamatergic, cholinergic and possibly other neurotransmission systems [3, 63, 142] , although the significance of this dependency is not fully understood.
An array of interactions has been identified between PARPs and sirtuins, adding to the multiple already described levels of sirtuin regulation (Fig. 1) , with increasingly recognized significance for the stress response, metabolic regulation and survival/ death decisions.
The multiple levels of sirtuin regulation SIRT1 to -7 are expressed in the brain and undergo regulation in response to a number of stimuli leading to high regional and developmental variation [169, 209] which is modified in the course of ageing [23] and numerous diseases. The transcriptional and post-transcriptional regulation of sirtuins ( Fig. 1A-C) occurs at all levels from mRNA expression to post-translational modifications and protein-protein binding. -A reciprocal relationship links sirtuins with TFs from the FOXO family. Although the majority of findings point to the influence of sirtuin on FOXOs (described below), there are results indicating that FOXOs are able to modulate sirtuin signalling (Fig. 1A, C) . The SIRT-1 gene contains several functional FOXO-responsive elements [219] . The signalling between sirtuins and FOXOs extensively cross-talks with the p53 pathway (Fig. 1A , C, Fig. 3A , B). The SIRT1 promoter contains p53-binding sites; p53 interacts there with FOXO3a, mediating the induction of SIRT1 expression by caloric restriction (CR) [144] . In the regulation of glucose metabolism, SIRT6 is important for the p53-dependent nuclear sequestration of FOXO1 [235] . p53 potentially could also impact sirtuins through its links with microRNAs, especially with the miR-34 family [171] . -A feedback mechanism links SIRT1 with the activity of E2F1 (E2 promoter binding factor), which senses stress conditions (oxidative/stress, CR) [206] : E2F1 activates SIRT1 gene transcription, while SIRT1 exerts feedback inhibition on its TF activity. E2F1 also suppresses Sirt6 expression, relieving the sirtuin's negative influence on glycolysis in cancer cells [217] . -Oxidative stress activates SIRT1 expression via APE1 (apurinic/apyrimidinic endonuclease-1), a DNA repair endonuclease that possesses much less understood secondary activity as a gene expression regulator [7] . 
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Apart from transcriptional regulation, sirtuin expression has been described to undergo modulation by RNA-binding proteins and non-coding regulatory RNAs.
-The stress-modulated HuR proteins (Hu antigen R, the name derived from the role in the paraneoplastic neurological Hu syndrome) stabilise Sirt1 mRNA [30] and can influence its alternative splicing [238] . -Sirt1 mRNA is down-regulated by an antisense long non-coding RNA [214] . -A number of microRNAs also reduce Sirt1 expression [175] , notably in the context of metabolic disturbances, i.e. in the course of obesity-induced changes in fat storage, regulation of mitochondrial numbers, and oxidative energetic metabolism [57] . Persistent down-regulation of Sirt1 is also observed in ageing. Like in obesity [57] , it is caused by elevated miRNA-34a [106, 184] , a proposed brain ageing marker [108] which is capable of modulating cellular senescence [9, 83] . A similar effect on senescence has been noted for other microRNAs that target Sirt1: miRNA-22 [81, 241] and miRNA-217 [129] . Sirt-1 reduction by up-regulated miRNA (miR-181) also occurs in the hippocampus of a mouse AD model (3×Tg) [170] . Sirtuin regulation by microRNAs might be in fact a widespread phenomenon in inflammatory and thus possibly neurodegenerative conditions: links exist between miRNA-34a, -132, -138, -217, -373-and -520c-mediated Sirt1 reduction with NF-κB signalling (at least in the periphery) [49, 115, 191, 220, 231] , and a reciprocal impact of NF-κB on Sirt1 expression via miRNA has been noted [94] . Some of the Sirt1-regulating miRNAs also respond to oxidative stress, further supporting their potential involvement in neurodegenerative insults [34] . Apart from Sirt1, also Sirt6 undergoes regulation by microRNAs. Although the results are much less numerous, they also suggest links with aging/ senescence and metabolic regulation [37] . Notably, potential feedback regulation between Sirt6 and miRNA-766 modifies the former's role in aging. SIRT6 undergoes reduction by miR-766; with increasing donor age, the re-programming potential of human fibroblasts and the SIRT6 levels fall while miRNA-766 increases. The SIRT6 3'-untranslated region binds miRNA-766 and the microR-NA reduces both SIRT6 expression and fibroblast re-programming potential. In turn, SIRT6 reduction could be linked to the increased acetylation of histones observed during ageing in the gene coding for miR-766 [180] . Besides direct suppression, microRNAs can also impact sirtuins indirectly via down-regulation of NAD+ biosynthesis [36] , or by affecting IIS components [89] , and can mediate IIS' modulation of sirtuins [176] . Beyond the translational level SIRT1 protein binds AROS (active regulator of SIRT1), a protein capable of differentiating its impact upon sirtuin activity depending on the cell status. In response to genotoxic insults in cancer cells AROS supports the inhibitory influence of SIRT1 on p53 [99] , while in normal cells the interaction is weak and incapable of modifying SIRT1 activity [102] . SIRT1 also interacts with DBC-1 (deleted in breast cancer-1), which inhibits its enzymatic activity and anti-apoptotic influence, also in a manner dependent on cell phenotype (normal vs. transformed) [10] .
SIRT1 protein also undergoes a number of covalent modifications. -Its nuclear translocation and activation in conditions of oxidative stress is mediated by JNK1 (Jun N-terminal kinase 1)-catalysed phosphorylation [143] . Inhibition of DNA damage-induced, p53-dependent apoptosis by SIRT1 occurs after its phosphorylation by CKII (casein kinase II) [93] . The pro-survival SIRT1 activation also takes place in response to its phosphorylation by DYRK1 and DYRK3 (dual specificity tyrosine phosphorylation regulated kinases) [68] . However, DNA damage may also lead to SIRT1 inhibition, which is done by MST1 (mammalian sterile 20-like kinase 1) [232] . -Lysine SUMOylation (small ubiquitin-like modifier)
is an activating event important for SIRT1 activity towards p53; de-SUMOylation of SIRT1 overrides its anti-apoptotic activity in stress conditions [227] . -Activating S-glutathionylation of SIRT1 by the redoxmodulated enzyme glutaredoxin 2 may be critical to the sirtuin's role in vascular development [24] . Besides these specific mechanisms of regulation, the activity of sirtuins has also been shown to be post-translationally de-stabilized and inhibited by products of oxidative damage to lipids such as 4-hydroxynonenal [27, 56] .
A number of further protein-protein interactions and post-translational sirtuin modifications are described below. They form part of the multiple feedback regulatory loops connecting sirtuins with their signalling targets.
Transcriptional and post-transcriptional regulators as sirtuin targets
Sirtuins post-translationally regulate vast numbers of proteins including histones, TFs and co-activators, and enzymes (Table I, Fig. 2 ). Deacetylation restores the affinity of inactivated core histones to DNA, thus allowing general gene silencing [82] (Fig. 2) . This mechanisms may constitute one of the ways sirtuins reduce overall metabolic rates [145] and improve neuron survival. However, binding to specific promoters (e.g. via interactions with sequence-specific proteins there) allows sirtuins to modify histones and affect chromatin structure also in a localized manner [21] .
Interactions with transcription factors is a major mechanism of sirtuins' influence on metabolism and cell fate. The links between TFs of the FOXO family and sirtuins are extensive (Figs. 2 and 3) [219] . Sirtuins modulate FOXOs directly; moreover, sirtuins also add another level of FOXO regulation via modulation of the IIS pathway: -SIRT1 deacetylates FOXO1 ( Fig. 2 ) with varying effects on its activity: FOXO1 deacetylation increases its TF activity on SIRT1 and some other genes [219] while suppressing it in other situations (possibly due to different protein complex composition/promoter sequence) [228] . SIRT1 also modulates FOXO1 through enhancement of its nuclear presence [55] and probably changes its target gene spectrum [62] . SIRT2 in turn facilitates DNA binding by FOXOs [207] ; deacetylation by SIRT2 inhibits the Akt-mediated nuclear sequestration of FOXO1 [88] (Fig. 3C ). This enhances the inhibitory influence FOXO1 exerts on PPARγ, thus mediating the changes in adipose metabolism induced by nutrient deprivation or exposure to low temperature [208] . FOXO3 and FOXO4 are also deacetylated by SIRT1 and 2; this exerts a complex influence on their downstream mediators including superoxide dismutase, p27 kip1 , and GADD45 (growth arrest and DNA damage 45) and target processes such as stress resistance cell cycle and death [25, 78, 101, 173, 207] C SIRT1 enhances IIS signalling -it occurs through at least two ways: -deacetylation of p53 leads to reduction of its protein levels, relieving IIS inhibition by the IGF-binding protein-3 [215] ; -SIRT1 can also directly deacetylate Akt, restoring its ability to bind phosphoinositides and become activated by phosphoinositide-dependent protein kinase 1 [192] ). These dependencies have already been confirmed to impact metabolic deregulation, cardiac dysfunctions and tumour formation, and might result in inhibition of the IIS target FOXO1 [67] . In addition to SIRT1, also SIRT2 can physically interact with Akt; the sirtuins may be exchanged depending on the activation state of the IIS pathways. SIRT2 is necessary for full activation of Akt in response to insulin/growth factor signalling, while a deficient Akt response is noted in metabolic disturbances including insulin resistance [164] . Together with the above-mentioned results it suggests an image of extremely tightly regulated, multi-level influence of SIRT2 on FOXO-mediated events. Besides direct interactions with FOXO3a, SIRT3 also has a potential indirect impact on FOXOs by moderating Akt overactivation by ROS [158] . SIRT6 has been shown to suppress IIS signalling-modulated genes [194] , resulting in reduced FOXO1 expression [193] . SIRT6 also mediates p53-induced nuclear sequestration of FOXO1 in the regulation of energy metabolism [235] .
The FOXOs' extensive interactions with various stress signalling and protein turnover pathways allow them to mediate a broad spectrum of homeostatic responses. Their role in the longevity/neuroprotective effects of IIS (insulin/insulin-like signalling)-dependent modulation of stress resistance is of particular importance. FOXOs' links may be crucial for the pathomechanism of a number of (mostly agerelated) diseases associated with disturbed somatic maintenance, including AD, leading to suggestions that they could constitute targetable integrating factors influencing various neurodegenerative mechanisms [125] .
The highly conserved tumour suppressor p53 and its paralogues (p63, p73) have long been known to take part in the DNA damage response, especially cell cycle arrest, cellular senescence, and death. These TFs are also capable of direct modulation of DNA repair genes and proteins [146] . Moreover, the p53 family could also be linked to ageing at the organism level [146, 160] . Other emerging roles of p53 in glucose and lipid metabolism, ROS signalling and oxidative stress [64] suggest a significant functional overlap with SIRT pathways. p53 undergoes extensive post-translational modifications of several types; this makes it sensitive inter alia to inhibition and destabilisation via sirtuin-catalysed deacetylation (Figs. 2 and 3B) . Moreover, SIRT1 binds and inhibits p53 promoter [52] ; SIRT1's interactions with the senescence modulator miRNA-34a also allow a post-transcriptional influence on p53 [77, 229] , while both SIRT1 and p53 can be miRNA-34a's targets as well [229] . SIRT1 expression increases in the conditions of H 2 O 2 -induced oxidative stress, and sirtuin activation inhibits p53-dependent apoptosis [240] . Down-regulation of SIRT1's influence on p53 mediates responses to several stressors in other cell types [204, 224] and to a range of age/hyperglycaemia-related vascular endothelial pathologies [107, 233] . Similar mechanisms of age-related, glucose-elicited damage might also be involved in neurodegenerative disorders along with generalized oxidative/nitrosative stress. Indeed, it is suggested that a significant part of SIRT1's neuroprotective signalling could be mediated through p53 [234] , including SIRT1's roles in AD and PD [39, 98, 151] . Sirtuin-mediated changes in p53 stability and TF activity also occur in an experimental model of hippocampal neuronal plasticity [112] .
Less characterised sirtuin family members have also been noted to signal through p53 (Fig. 3B) . Administration of a SIRT2 inhibitor resulted in increased p53 acetylation [226] . The influence of SIRT2 on p53 appears to be complex; it can either block its trans-activating influence on gene expression (via direct deacetylation) [87] , or enhance its degradation [18] , sometimes only when working in concert with SIRT1 [153] . SIRT3 is able to modulate p53 degradation mediated by MDM2 (mouse double minute 2 homolog), and the influence p53's role as a metabolic regulator [237] . SIRT6 also takes part in p53's modulation of energy metabolism via nuclear sequestration of FOXO1 [235] . A recently identified cytoplasmic pool of SIRT7 binds p53 in a complex with TPPII (tripeptidyl-peptidase II, also capable of modulating NF-κB) [141] .
Moreover, sirtuins also interact with an important partner of p53 and NF-κB, p300 (Figs. 2 and 3B ). p300 is a transcriptional co-activator able to block the interaction of histones with DNA through their acetylation. However, p300 is also able to reduce p53 stability via its negative regulator MDM2, in a manner that appears to depend on the type of upstream signals or on cell type [109] . SIRT1 can inhibit the acetylating activity of p300 [22] , which might exert a pro-survival influence in AD [48] . However, the influence of SIRT2 on p300 appears to be opposite to that of SIRT1 [18] , as mentioned above in the context of p53 degradation. In turn, p300 inhibits SIRT2 through acetylation, attenuating its negative influence on p53 [73] .
The NF-κB pathway has been proposed to be a nearly universal booster of the innate immunity and pro-inflammatory responses that largely counteracts the FOXO system [173] . NF-κB activity often significantly contributes to neuronal damage in AD, ischaemia, and other disorders; the blockage of NF-κB-dependent gene transactivation by sirtuin signalling offers neuroprotection in amyloid β (Aβ) toxicity [32] . Moreover, the regulatory activities of NF-κB are altered during ageing [76] , while NF-κB is capable of modulation of ageing/senescence largely via its sirtuin interactions [96] . Despite varying intracellular localisations and interactions repertoires, most sirtuins modulate NF-κB, often in a negative manner. -SIRT1 inhibits NF-κB (Fig. 2) through: -deacetylation of the RelA subunit of NF-κB (this RelA modification is dependent on p300 or PCAF -the p300/CBP-associated factor) [230] ; -interactions with NF-κB's transcriptional corepressor TLE1 (transducin-like enhancer protein 1) [61] . -SIRT2 is also able to inhibit the TF via deacetylation of p65 (Lys 310) (Fig. 3C) ; [117] . However, its known positive influence on p300 [18] suggests that the regulatory interactions between these proteins might be significantly more complex than currently known. -SIRT3, itself a transcriptional target of NF-κB [116] , mediates the inhibitory effect of metformin on NF-κB in a cellular model of oxidative stress and insulin resistance [185] . In contrast, in a different cell line SIRT3 has been found to activate H 2 O 2 -induced, NF-κB-dependent expression of, inter alia, superoxide dismutase [31] , strongly suggesting that the interaction is promoter-specific and/or modified by further interactions. -SIRT4 blocks the degradation of IκB (inhibitor of κB) [33] and reduces the nuclear translocation of NF-κB and resulting pro-oxidative and pro-inflammatory phenotype [196] . -SIRT6 binds RelA and is able to repress NF-κB target promoters that become activated during aging [96] , and can delay cellular senescence [218] . However, the effect has not been observed in some other models/conditions [65] , possibly due to the dynamic and interdependent character of the interaction with NF-κB [97] . -Besides these, the sirtuin target FoxO3a interacts with NF-κB [111] and with its PI-3K (phosphoinositide 3-kinase)/Akt-dependent upstream activator IKKβ (IκB kinase β) [154] , which suggests additional paths of influence. Sirtuins thus simultaneously impact the pro-inflammatory and potentially deleterious actions of NF-κB and activate FOXO somatic maintenance signalling [173] . The effect may modulate the stress resistance signals of IIS, which is able to regulate both FOXOs and NF-κB [70] .
The family of hypoxia-inducible factors (HIFs) modulates, inter alia, energy metabolism and the stress response depending on oxygen concentration. SIRT1 inhibits HIF1 [110] but activates HIF2 (Fig. 2) [45] , while SIRT6 may be a co-repressor for HIF-1α [242] . The significance of this discrepancy has not been extensively tested, but invertebrate data suggest engagement of HIFs in the modulation of ageing rates. Moreover, HIFs' transactivation targets include genes with known neuroprotective products, although it has been suggested that these TFs might play either protective or detrimental roles [54, 86, 140, 223] .
The sirtuin interaction partners peroxisome proliferator-activated receptors (PPARα, PPARβ/δ, PPARγ) are a class of nuclear receptors, TFs whose intracellular localization and activity are regulated by ligand binding. PPAR roles include metabolic regulation in response to environmental cues, proliferation control, and cardiovascular homoeostasis; they modulate oxidative stress, inflammation, or insulin resistance. PPARs can antagonize neurodegeneration in AD/PD/cerebral ischaemia/brain trauma [139, 161] . They may also be of therapeutic interest in the metabolic syndrome [58] . PPARs also modulate inflammation that partially mediates these pathologies [58, 139, 161, 165] . PPARs may also constitute plausible targets in diabetes and diabetes-linked neuropathy.
SIRT1 is involved in a two-directional interaction with PPARα. SIRT1 binds PPARα on its DNA response elements. The binding is tightly regulated depending on the DNA sequence [150] . The resulting deacetylation enhances PPARα activity [167] (Fig. 2) . SIRT1 also facilitates the protein-protein interaction between PPARα and NF-κB (p65) [159] . Sirt1 and PPARα genes are regulated in a coordinate manner by the ageing-linked miRNA-22 [69] and miRNA-34a [44] , while SIRT1 is able to modulate miRNA-34a in concert with p53 [77] . This suggests a precisely regulated feedback mechanism, but the potentially significant topic has not been explored much further. The widely used natural sirtuin activator resveratrol has been shown to bind and activate PPARα directly [195] . SIRT1 also reverses the p300-dependent acetylation of PPARγ [72] and seems to inhibit its transactivation function [156] . PPARα, PPARγ, and PPARδ agonists were able to increase SIRT1 expression [35, 100, 213] ; PPARα activation also blocked SIRT1 export from the nucleus [213] . The Sirt5 gene promoter contains potential PPARα-responsive sequences, and the PPARα agonist is able to increase its expression [26] . Besides SIRT1, also SIRT6 displays links with the signalling network of PPARs [225] .
Not surprisingly, the interactions between sirtuin and PPAR pathways profoundly modulate energy metabolism [26] and appear to have an impact on a number of pathophysiological conditions (Fig. 2) . SIRT1 is involved in a potential senescence-related feedback interaction with PPARγ [72] . PPARγ is widely present in the brain (neurons and microglia), lowers local levels of iNOS (inducible nitric oxide synthase) and COX-2 (cyclooxygenase-2), and might constitute an effective target in the treatment of ischaemia [42] . Moreover, the impact of metabolic stress on SIRT1-PPARγ signalling has been suggested to modulate β-secretase and thus the rate of amyloid β production in AD [211] . Additionally, differential expression of Sirt1 and PPARγ has been noted in Aβ-treated glia, which would fit the above-mentioned antagonistic regulation of Sirt1 by PPARγ; it has been proposed to mediate the neuroprotective reaction of astrocytes elicited by in vitro Aβ treatment [4] . Outside the brain, PPARα is one of the effectors of SIRT1's cardioprotective actions [159] , although in some circumstances the SIRT1-PPARα interaction may actually promote heart hypertrophy [149] .
PPARγ co-activator 1α (PGC-1α) is an important player in the PPAR network, capable of modulating respiration/oxidative stress resistance [183] and neuronal survival. Its ASN-induced [221] disturbances may be implicated in the pathogenesis of Parkinson's disease [40] , and PGC-1α has been proposed as a therapeutic target in PD [239] .
PGC-1α regulates mitochondrial biogenesis by working together with SIRT1 [8] . SIRT1 reverses the p300-mediated acetylation of PGC-1α in a unique nuclear-mitochondrial cross-talk [8] . Additionally, SIRT1 binds the PGC-1α promoter and takes part in its positive regulation loop [6] . An interesting interaction takes place between PGC-1α and SIRT6: the sirtuin deacetylates and activates the acetyltransferase GCN5 (general control non-repressed protein 5), which leads to increased acetylation of PGC-1α and inhibition of its transcriptional co-activator function [46] . PGC-1 has been proposed to mediate the protective SIRT1/PPAR-dependent action of Aβ-challenged astrocytes towards neurons (the increase of neuronal biogenesis of mitochondria and survival in the co-culture with astroglia) [4] .
AP-1 (activator protein-1) is a dimeric TF consisting of proteins from Fos and Jun families, with a wide variety of roles in development, cell proliferation, survival and migration, and ROS (reactive oxygen species)/low oxygen signalling [133, 181] . AP-1 has been implicated in the control of brain plasticity and damage [162] , including a hypothesized central role in AD/PD [166] , and of numerous peripheral functions.
SIRT1 exerts a varied, context-specific influence on the transactivation of genes by AP-1 to modulate processes ranging from cyclooxygenase expression to pathogen replication [168, 236] . The Sirt3 gene contains an AP-1 binding site [15] in its longevity-correlating intronic enhancer [16] . As alleles displaying the lowest activity of this enhancer are notably absent from the oldest old group, the interaction may have strong significance for the modulation of human lifespan [16] . SIRT6 (which has also been associated with lifespan modulation via IIS [92] ) binds c-Jun, undergoes recruitment to its target promoters and reduces their activity via histone deacetylation [193] . c-Fos is able to induce transcription of the Sirt6 gene; the sirtuin in turn represses survivin via NF-κB. The significance of apoptotic resistance regulation by AP-1-SIRT6 signalling in the survival of pre-neoplastic lesions is further strengthened by the observation that both display specific expression patterns in pathological tissue samples [134] .
Further elucidation should cast more light on sirtuin-AP-1 cross-talk, which could have significant consequences for, inter alia, brain development, homeostasis, learning and memory, and neurodegenerative conditions [162] .
While microRNAs are an emerging mechanism of sirtuins' gene regulation, relatively little is known about the possible specific impact of sirtuins on miRNA metabolism (see above, PPAR section).
Sirtuins and DNA repair
The interaction with stress-related TFs may have vast significance for the regulation of DNA repair by sirtuins. Additionally, some TFs (such as FOXO3a, p53, NF-κB, E2F1, Sp1 -specificity protein-1, or some nuclear receptors) have also been implicated in the repair process itself, possibly via relaxation of chromatin structure, though the matter still needs some clarification [124, 201] . However, sirtuins are able to directly influence proteins involved in the repair of macromolecular damage.
-Apurinic/apyrimidinic endonuclease 1 (APE1) is one of the crucial factors involved in the base excision repair (BER) pathway which removes the ubiquitous products of free radical-related damage from DNA. APE1 has been shown to be inactivated by acetylation at multiple sites [222] . SIRT1 binds APE1 and deacetylates two of its lysines. This stimulates APE1 to bind its partner XRCC1 (X-ray cross-complementing-1) and increases its activity in the BER complex. The net effect of sirtuin-mediated stimulation of APE1 is an improvement of the efficiency of this crucial repair mechanism, as measured by reduced levels of abasic sites in DNA [222] . -SIRT1 is also known to facilitate the activity of nucleotide excision repair (NER), a mechanism that removes a wide spectrum of DNA lesions/adducts and has demonstrated crucial significance in cancer prevention. SIRT1 deacetylates two lysines of the core NER protein XPA (xeroderma pigmentosum group A); this reaction is necessary for the full efficiency of UV damage removal [50] . SIRT1 also relieves the repression of the XPC gene coding for a protein that recognizes DNA lesion and recruits other NER components [135] . Table II . Mammalian PARP enzymes. According to [79, 205] , modified -DNA-dependent protein kinase (DNA-PK) is in volved in non-homologous end-joining (NHEJ) repair, which neutralises double-strand breaks, a highly mutagenic and lethal type of DNA lesion. DNA-PK is also an anti-apoptotic signalling protein. The Ku70 subunit of DNA-PK undergoes inhibitory acetylation on at least 8 lysines by, inter alia, PCAF (p300/CBP-associated factor), a histone acetyltransferase that also collaborates in DNA damage signalling with p53 [179] . SIRT1 associates with and deacetylates Ku70, thus activating DNA-PK in both its roles [41, 85] . SIRT6 also appears to be involved in DNA maintenance [21] and modulates the binding of DNA-PK to regions of DNA double-strand breaks, thus facilitating the removal of these deleterious lesions [127] . -SIRT6 was observed to be an important factor in telomere maintenance through deacetylation of histone H3. Moreover, SIRT6 appears to stabilize the association of Werner protein with telomeric chromatin, further contributing to the regulation of its architecture [131] .
Sirtuins and PARPs
Sirtuins interact in a complex way with the versatile family of Poly(ADP-ribose) polymerases (PARPs) ( Table II, Fig. 4 ). The roles of various PARPs include DNA repair (modulated chiefly by PARP-1 to -3), regulation of gene transcription (PARP-1, -2, and structurally different macroPARPs: PARP-9, -14, -15) [128] , RNA processing in the nucleus and cytoplasm (PARP-1, -7, -10, -12 to -15, tankyrase-1) [19] , cellular RNA transport (probable role of vault PARP and PARP-10) [1] , cellular transport of proteins (mainly PARP-16) [1] , and telomere maintenance (somewhat ambiguously including PARP-1, tankyrase-1 and possibly tankyrase-2) [174, 177] .
The family's founding member PARP-1 detects DNA damage (single-and double-strand breaks, abnormal spatial structures) and post-translationally modifies histones to locally de-condensate chromatin, thus facilitating access for the repair machinery [190] . It also directly recruits and modulates DNA repair proteins involved in BER, NER, NHEJ, and homologous recombination DNA repair pathways, and numerous signalling proteins [188] . Besides regulating chromatin accessibility [199] , PARPs can act more specifically, as activators/co-activators or (co-) repressors for numerous TFs. PARP-1 modulation of transcription factors impacts both gene regulation and the recently identified role of TFs in DNA repair [84, 124] .
The extensive network of interactions between PARP-1 and the p53 pathway cross-talks with other post-translational modifiers [216] , possibly including sirtuins [138] , with vast significance for most previously identified PARP functions [74] . The co-operation between PARP-1 and numerous TFs also includes NF-κB and is important for neurodegeneration in Alzheimer's disease [95] , for brain ischaemia [80] , etc. Despite the pro-survival physiological significance of PARP-1, its excessive activation by DNA damage induced by ROS/RNS (reactive nitrogen species) [187] , Aβ, or mutagens [189] has long been associated with cell death. The long-postulated theory of passive cellular demise via stress-induced energy imbalance suggested that PARP over-activation by intense DNA damage would lead to massive PARylation, depleting cellular stores of NAD + and consequently ATP (which is used to re-synthesize it). However, more recent works have suggested that in post-mitotic cells nuclear NAD + depletion itself could be more significant, inhibiting some crucial enzymes that utilise the nucleotide as a substrate [157] . PARP-1's K M towards NAD + should be low enough to make it relatively insensitive to the changes of NAD + concentration and to allow continued activation despite ongoing metabolic disruption. In contrast, the nuclear SIRT1 displays K M closer to the reported intracellular NAD + levels and thus should be significantly influenced by such pathophysiological changes [28, 157] . Indeed, cell death caused by PARP over-activation was rescued by various interventions that boosted NAD + levels and occurred only in the presence of the intact SIRT1 orthologue Sir2α [157] . Increased activity of SIRT1 in PARP-1 -/-mice was also noted [12] . The PARP-sirtuin substrate competition has already been confirmed to impact SIRT1 downstream events linked to the regulation of cell death/survival [157] or mitochondrial metabolism [12] . Disruption of the SIRT1-PGC-1α axis by (over)activated PARP-1 has been suggested to be of significance for the pathomechanism of several DNA repair disorders accompanied by neurodegeneration where mitochondrial abnormalities may play significant roles [51, 178, 200] . SIRT1 inhibition via NAD + depletion might also mediate other neurodegenerative insults such as the death of hippocampal cells in culture in a model of acute epileptic neuron loss [212] .
Sirtuins other than SIRT1 also display K M that would suggest dependency on PARP-induced NAD + fluctuations. However, the phenomenon of inactivation by PARP-mediated substrate competition appears to be restricted to SIRT1. The (in)sensitivity of various sirtuins to competition with PARP-1 might stem from several factors, including their intracellular localisation and their ability or not to pre-bind NAD + and thus escape the NAD + depletion [28] . Moreover, in some situations sirtuin inhibition by oxidative stress may be direct and not mediated by the competition with PARPs for the substrate [27] .
Yet other mechanisms of cross-talk might exist, as both PARP-1 [147, 148] and SIRT1 [17] interact with YY1 (yin yang 1). YY1 is an important regulator of miRNAs and protein-coding genes related to neuronal plasticity [59] and degeneration [104] as well as DNA repair [147] . A potentially significant topic for sirtuin regulation is the observed impact of PARP-1 on both upstream modulators and signalling targets of sirtuins. PARP-1 appears to be critically involved in the modulation of Akt activity [91, 186] ; however, despite its importance for, inter alia, neurodegeneration [130] , or ischemic damage [105] the mechanism of this interaction has not been explored further. PARP-1 also directly binds and PARylates FOXO1, leading to suppression of FOXO1-dependent genes [172] .
The more favourable K M of PARP-1 should allow it to out-perform SIRT1 in the competition for NAD + in all situations [12] . However, both enzymes are able to block each other's activity by releasing the inhibitory by-product nicotinamide [103] . SIRT1 has also been able to mitigate the rapid PARP-1 activation in oxidative (H 2 O 2 -induced) stress while SIRT1 knock-out has led to enhanced apoptotic signalling and cell loss in these conditions [103] . The results obtained by Rajamohan suggest that depending on the conditions the difference in K M could be negligible: the value for PARP-1 activated by pERK or the histone acetyltransferase PCAF (p300/CBP-associated factor) is just 10% to 20% lower than that of SIRT1 [163] .
The activation of PARP-1 by PCAF in stress conditions occurs via acetylation [163] , making it a good substrate for SIRT1. SIRT1 has been shown to interact with and de-acetylate PARP-1 [163] , reversing its enzymatic stimulation and reducing it to nearly undetectable levels. Surprisingly, acetylation boosted only the basal activity of PARP-1 and not its maximum, DNA damage-induced activity. However, removal of this modification inhibited PARP's (mechanical stress-related) activation, thus potentially offering some cytoprotective potential [163] . Although the physical interaction between SIRT1 and PARP 1 is dependent on NAD + availability and gradually diminishes with its increasing concentration, SIRT1 prebound to NAD + is still able to bind PARP-1 physically (and possibly deactivate it) despite the lack of substrate. This suggests a potential mechanism for pre-serving SIRT1 activity despite NAD + depletion [163] . Most work on SIRT1-mediated PARP-1 inhibition has been done on cell lines of non-neuronal origin. However, it has been shown that the influence of SIRT1 on PARP-1 can indeed be of significance in oxidative stress conditions, thus raising hopes for using it as a potential target in neurodegeneration. The absence of SIRT1 sensitized the cells via PARP to H 2 O 2 -induced death [103] , while over-expression of SIRT1 in HeLa cells reduced PARP-mediated, DNA damage-induced death in a mode dependent on its deacetylase function [163] .
SIRT1 is capable of modulating not only PARP-1 protein but also its gene expression. SIRT1 over-expression in cardiomyocytes has been shown to reduce PARP-1 gene promoter activity and PARP-1 mRNA, which translated into lower protein levels; deacetylase activity was necessary for the effect. SIRT1 did not appear to influence the degradation of PARP-1 protein, as shown in experiments with proteasomal and lysosomal inhibitors [163] .
Other PARPs (Figs. 1B and 4 ; Table II) , whose activities typically fall well below those of PARP-1, are able to modulate sirtuins in ways independent of NAD + fluctuations. [11] . PARP-2 is a direct negative regulator of the SIRT1 promoter, and its impact on the SIRT1 gene has direct consequences for energetic metabolism and mitochondrial function (Fig. 4 ) [137] . PARP-7, or tetrachlorodibenzo-p-dioxin-inducible poly(ADP-ribose) polymerase (TiPARP), appears to have the ability to inhibit SIRT3 activity (but not mRNA expression) in conditions of oxidative stress (Fig. 4) ; this leads to reduced expression of superoxide dismutase-2 and might further exacerbate the damage [75] .
It is not clear if the acetylated residues present in PARPs other than PARP-1 could be targeted by sirtuins or if these isoforms are able to significantly affect SIRT activities.
The influence of SIRT2 to -7 on PARPs is not fully determined. A rather unusual interaction takes place between SIRT6 and PARP-1 [126] . SIRT6 resides largely in the heterochromatin; it is recruited to double-strand break sites and its expression is enhanced in response to DNA damage. Its stimulatory effect on DNA repair was visible both under resting and stress conditions evoked by paraquat (producing superoxide), neocarzinostatin (a singleand double-strand break inducer) or H 2 O 2 . SIRT6 physically binds PARP-1 in a manner enhanced by the damage and mono(ADP ribosyl)ates it on Lys521. PARP-1 enzymatic activity is stimulated by this interaction and mediates the positive effect of SIRT6 on the efficiency of NHEJ and homologous recombination repair (Fig. 4) ; [126] . Although SIRT6 did not influence the acetylation level of PARP1, both SIRT6 enzymatic activities have been found to take part in the regulation of DNA repair [126] . The opposite influence of SIRT1 and -6 on PARP activity prompted Cantó et al. to suggest that these proteins could constitute a signalling switch in the DNA repair network [28] . In an example scenario, ATM (ataxia-telangiectasia mutated), which senses DNA damage, would phosphorylate DBC-1 protein, facilitating its inhibitory influence on SIRT1. This would remove the inhibition of PARP-1, thus leaving only the positive influence of SIRT6 and allowing PARP-1 to efficiently perform its protective function [28] .
The described unique characteristics of sirtuins correspond to their broad links to signalling pathways and enzymes involved in cellular maintenance and the stress/damage response. Some sirtuins localise to mitochondria and modulate their biogenesis as well as the function of the respiratory machinery. Moreover, sirtuins are capable of influencing anti-oxidative proteins and the unfolded protein response there, as well as the mitochondrial cell death signalling. A growing body of evidence links sirtuins to aging and neurodegenerative diseases, making these HDACs highly promising research and therapeutic targets.
